Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) saw unusually-high trading volume on Thursday . Approximately 95,856 shares changed hands during mid-day trading, an increase of 171% from the previous session's volume of 35,384 shares.The stock last traded at $127.15 and had previously closed at $127.34.
Analyst Ratings Changes
HOCPY has been the topic of a number of recent analyst reports. Erste Group Bank raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a research report on Friday, May 23rd. The Goldman Sachs Group raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, July 23rd.
Check Out Our Latest Analysis on Hoya
Hoya Stock Down 0.2%
The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 4.21. The company has a market cap of $43.61 billion, a price-to-earnings ratio of 33.36, a P/E/G ratio of 2.52 and a beta of 0.90. The firm's 50 day simple moving average is $120.30 and its 200-day simple moving average is $120.23.
Hoya (OTCMKTS:HOCPY - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The technology company reported $0.98 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.99 by ($0.01). Hoya had a net margin of 23.22% and a return on equity of 20.43%. The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.50 billion. As a group, sell-side analysts anticipate that Hoya Corp. will post 3.66 earnings per share for the current year.
About Hoya
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.